Back to search
Atypical Hyperplasia of the Breast
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Hyperplasia of the Breast trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Atypical Hyperplasia of the Breast trials you may qualify forThis phase II trial evaluates tamoxifen, with or without omega-3 fatty acids, for reducing risk of breast cancer among postmenopausal and overweight or obese wo…
This phase IIA trial compares the effect of acolbifene versus low dose tamoxifen in preventing breast cancer in premenopausal women at high risk for developing…
This study evaluates the association of dietary inflammatory potential with breast cancer risk. Information collected in this study may help doctors to identify…
This trial studies the implementation of web-based decision support tools for patients with atypical hyperplasia or lobular carcinoma in situ and healthcare pro…
This randomized controlled trial compares vacuum-assisted percutaneous excision to open standard surgical excision in women who have high-risk or borderline, no…
The investigators plan to prospectively study breast tissue changes after a short course of Tamoxifen (Tam).